EUVIMEDEUVIMED entdecken
Crossref

Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel

Junge Chen, Fengqiang Cao, Yang Cao, Shujin Wei, Xiurui Zhu, Wanli Xing

Journal of Biomedical Nanotechnology · 01.04.2022 · 18 (4) · 1075-1083

DOI: 10.1166/jbn.2022.3278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Nanotechnology, erschienen am 01.04.2022. Verfasst von Junge Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Exosomes, Lung Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the most common cancer throughout the world. Currently, most lung cancer therapies are still limited by serious side effects caused. This paper reports a biocompatible drug delivery system that utilizes milk-derived exosomes to deliver paclitaxel to treat lung adenocarcinoma. First, milk-derived exosomes were modified with integrin α V β 3 , α V β 5 -binding peptide iRGD so that they could successfully target lung adenocarcinoma cells. Then, iRGD modified exosomes were loaded with paclitaxel (PAC) via electroporation and used for tumor therapy. These modified exosomes proved effective in killing lung adenocarcinoma cells, and the exosome-based nanoplatform showed no obvious toxicity to normal cells. Further more, the exosome-based nanoplatform could effectively penetrate the interior of the 3D tumor sphere, reaching more tumor cells and demonstrating that it is a promising tool for lung adenocarcinoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungExosomesLung NeoplasmsAnimalsCell Line, TumorHumansMilkPaclitaxel

Substanzen

Paclitaxel

Autor:innen und Institutionen

  • Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang University, Beijing, 100083, China.
  • Graduate School of Bio-Applications Systems Engineering, Tokyo University of Agriculture and Technology, Tokyo, 184-8588, Japan.
  • School of Medicine, Tsinghua University, Beijing, 100084, China.
  • Department of Cardiothoracic Surgery, School of Medicine, Stanford University, California, 94305, USA.

Zitieren

APA

Chen, J., Cao, F., Cao, Y., Wei, S., Zhu, X., & Xing, W. (2022). Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel. Journal of Biomedical Nanotechnology, 18(4), 1075-1083. https://doi.org/10.1166/jbn.2022.3278

Vancouver

Chen J, Cao F, Cao Y, Wei S, Zhu X, Xing W. Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel. Journal of Biomedical Nanotechnology. 2022;18(4):1075-1083. doi:10.1166/jbn.2022.3278

BibTeX
@article{Chen2022,
  author = {Chen, Junge and Cao, Fengqiang and Cao, Yang and Wei, Shujin and Zhu, Xiurui and Xing, Wanli},
  title = {Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel},
  journal = {Journal of Biomedical Nanotechnology},
  year = {2022},
  volume = {18},
  number = {4},
  pages = {1075--1083},
  doi = {10.1166/jbn.2022.3278}
}
Kostenlos starten →